Drug Pipeline

NBI-1065845 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
3
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07196501 A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in… Major Depressive Disorder Recruiting
NCT06963021 NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an… Major Depressive Disorder Recruiting
NCT06966401 Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive… Major Depressive Disorder Recruiting
Sponsors Running NBI-1065845 Trials
Neurocrine Biosciences (3)
Disease Areas
Depression (3)
Get alerts when NBI-1065845 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free